BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36587067)

  • 1. Chemical Synthesis and Molecular Interaction Analysis of α-Galactosyl Ceramide Derivatives as CD1d Ligands.
    Ueki K; Sueyoshi K; Inuki S; Fujimoto Y
    Methods Mol Biol; 2023; 2613():13-22. PubMed ID: 36587067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and Discovery of Covalent α-GalCer Derivatives as Potent CD1d Ligands.
    Kishi J; Inuki S; Kashiwabara E; Suzuki T; Dohmae N; Fujimoto Y
    ACS Chem Biol; 2020 Feb; 15(2):353-359. PubMed ID: 31939653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationship studies of Bz amide-containing α-GalCer derivatives as natural killer T cell modulators.
    Kishi J; Inuki S; Hirata N; Kashiwabara E; Yoshidome D; Ichihara O; Fujimoto Y
    Bioorg Med Chem Lett; 2019 Apr; 29(8):970-973. PubMed ID: 30824201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human and mouse type I natural killer T cell antigen receptors exhibit different fine specificities for CD1d-antigen complex.
    Wun KS; Ross F; Patel O; Besra GS; Porcelli SA; Richardson SK; Keshipeddy S; Howell AR; Godfrey DI; Rossjohn J
    J Biol Chem; 2012 Nov; 287(46):39139-48. PubMed ID: 22995911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Avidity of CD1d-ligand-receptor ternary complex contributes to T-helper 1 (Th1) polarization and anticancer efficacy.
    Wu TN; Lin KH; Chang YJ; Huang JR; Cheng JY; Yu AL; Wong CH
    Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17275-80. PubMed ID: 21987790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative microarray analysis of intact glycolipid-CD1d interaction and correlation with cell-based cytokine production.
    Liang PH; Imamura M; Li X; Wu D; Fujio M; Guy RT; Wu BC; Tsuji M; Wong CH
    J Am Chem Soc; 2008 Sep; 130(37):12348-54. PubMed ID: 18712867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NKT TCR recognition of CD1d-α-C-galactosylceramide.
    Patel O; Cameron G; Pellicci DG; Liu Z; Byun HS; Beddoe T; McCluskey J; Franck RW; Castaño AR; Harrak Y; Llebaria A; Bittman R; Porcelli SA; Godfrey DI; Rossjohn J
    J Immunol; 2011 Nov; 187(9):4705-13. PubMed ID: 21964029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural evaluation of potent NKT cell agonists: implications for design of novel stimulatory ligands.
    Schiefner A; Fujio M; Wu D; Wong CH; Wilson IA
    J Mol Biol; 2009 Nov; 394(1):71-82. PubMed ID: 19732779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential recognition of CD1d-alpha-galactosyl ceramide by the V beta 8.2 and V beta 7 semi-invariant NKT T cell receptors.
    Pellicci DG; Patel O; Kjer-Nielsen L; Pang SS; Sullivan LC; Kyparissoudis K; Brooks AG; Reid HH; Gras S; Lucet IS; Koh R; Smyth MJ; Mallevaey T; Matsuda JL; Gapin L; McCluskey J; Godfrey DI; Rossjohn J
    Immunity; 2009 Jul; 31(1):47-59. PubMed ID: 19592275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Introduction of aromatic group on 4'-OH of α-GalCer manipulated NKT cell cytokine production.
    Zhang W; Xia C; Nadas J; Chen W; Gu L; Wang PG
    Bioorg Med Chem; 2011 Apr; 19(8):2767-76. PubMed ID: 21439833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presentation of alpha-galactosylceramide by murine CD1d to natural killer T cells is facilitated by plasma membrane glycolipid rafts.
    Lang GA; Maltsev SD; Besra GS; Lang ML
    Immunology; 2004 Jul; 112(3):386-96. PubMed ID: 15196206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of a 2"-deoxy-β-GalCer.
    Thakur MS; Khurana A; Kronenberg M; Howell AR
    Molecules; 2014 Jul; 19(7):10090-102. PubMed ID: 25014535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A minimal binding footprint on CD1d-glycolipid is a basis for selection of the unique human NKT TCR.
    Wun KS; Borg NA; Kjer-Nielsen L; Beddoe T; Koh R; Richardson SK; Thakur M; Howell AR; Scott-Browne JP; Gapin L; Godfrey DI; McCluskey J; Rossjohn J
    J Exp Med; 2008 Apr; 205(4):939-49. PubMed ID: 18378792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular basis for recognition of CD1d/α-galactosylceramide by a human non-Vα24 T cell receptor.
    López-Sagaseta J; Kung JE; Savage PB; Gumperz J; Adams EJ
    PLoS Biol; 2012; 10(10):e1001412. PubMed ID: 23109910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor.
    Borg NA; Wun KS; Kjer-Nielsen L; Wilce MC; Pellicci DG; Koh R; Besra GS; Bharadwaj M; Godfrey DI; McCluskey J; Rossjohn J
    Nature; 2007 Jul; 448(7149):44-9. PubMed ID: 17581592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes.
    Nishimura T; Kitamura H; Iwakabe K; Yahata T; Ohta A; Sato M; Takeda K; Okumura K; Van Kaer L; Kawano T; Taniguchi M; Nakui M; Sekimoto M; Koda T
    Int Immunol; 2000 Jul; 12(7):987-94. PubMed ID: 10882410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-Function Implications of the Ability of Monoclonal Antibodies Against α-Galactosylceramide-CD1d Complex to Recognize β-Mannosylceramide Presentation by CD1d.
    Clark K; Yau J; Bloom A; Wang J; Venzon DJ; Suzuki M; Pasquet L; Compton BJ; Cardell SL; Porcelli SA; Painter GF; Zajonc DM; Berzofsky JA; Terabe M
    Front Immunol; 2019; 10():2355. PubMed ID: 31649670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The crystal structure of human CD1d with and without alpha-galactosylceramide.
    Koch M; Stronge VS; Shepherd D; Gadola SD; Mathew B; Ritter G; Fersht AR; Besra GS; Schmidt RR; Jones EY; Cerundolo V
    Nat Immunol; 2005 Aug; 6(8):819-26. PubMed ID: 16007090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycolipids that elicit IFN-γ-biased responses from natural killer T cells.
    Tyznik AJ; Farber E; Girardi E; Birkholz A; Li Y; Chitale S; So R; Arora P; Khurana A; Wang J; Porcelli SA; Zajonc DM; Kronenberg M; Howell AR
    Chem Biol; 2011 Dec; 18(12):1620-30. PubMed ID: 22195564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen.
    Hameg A; Apostolou I; Leite-De-Moraes M; Gombert JM; Garcia C; Koezuka Y; Bach JF; Herbelin A
    J Immunol; 2000 Nov; 165(9):4917-26. PubMed ID: 11046017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.